Predicting GLP-1 Discontinuation From Pharmacy Claims
Published: | Updated:
|Articles|June 1, 1996
Supplements and Featured Publications
- Managing the Patient at Risk for NSAID Toxicity Consensus Conference
- Volume 2
- Issue 8 Suppl
Goals and Long-Term Management of Arthritis with NSAIDs
Author(s)Thomas J. Schnitzer, MD, PhD
Advertisement
Articles in this issue
about 30 years ago
Participantsabout 30 years ago
Defining the Patient at Risk for NSAID Toxicityabout 30 years ago
Overview of the Physiology of COX-1 and COX-2 and Selectivity of NSAIDsabout 30 years ago
GI Toxicity of NSAIDs: Incidence, Complications, Management Strategyabout 30 years ago
Reaching Consensus on Managing the Patient at Risk for NSAID ToxicityAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
Trump Childhood Vaccine Order: What It Means for Parents and Payers
2
FDA Proposes GRAS Rule, Advances Ultra-Processed Food Definition
3
Access, Coverage, and Final Reflections on Managing Alzheimer's Disease Agitation
4
Orelabrutinib Cuts Progression Risk 68% in Frontline CLL/SLL
5